Peters William J sold 12,631 shares of Amphastar Pharmaceuticals, Inc. at $28.99 for −$366k on Nov 5, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
CFO, EVP & TREASURER
CFO, EVP & TREASURER
Filed Nov 6, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$366,189.11Shares × reported price
Shares traded
12,631Common Stock
Price per share
$28.99Reported price. Read footnotes for ranges.
% of reported position traded
7.03%This security and ownership context
Holdings after
167,076Direct
Trade date
Nov 5, 2026Sell
Filed
Nov 6, 2026, 4:17 PM ET1-day reporting delay
Accession
0001263136-26-000016Code S · Transaction 394782
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 179,707 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 4, 2026Sell16,000$28.03−$448,480Trade 394780
Nov 4, 2026Option exercise16,000$0.00$0Trade 394783
Nov 5, 2026Option exercise11,000$0.00$0Trade 394784
Nov 4, 2026Option exercise16,000$13.03$208,480Trade 394779
Nov 5, 2026Option exercise11,000$17.99$197,890Trade 394781
6 transaction rows in this filing. Joint filers share the same rows.

AMPH price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
AMPH · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +1.3%1w ago 0%1d ago 0%
Returns since7d +15%30d90d180d1y

Footnotes in full

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2026. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.99 to $29.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3: Shares subject to the option are fully vested and immediately exercisable.